l-carnitine and iron deficiency CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, CARDIOVASCULAR DISEASE Carnitine deficiency and liver cirrhosis.

Specifically, we applied genetic proxies for l-carnitine to genome-wide association studies (GWAS) of CVD and its risk factors (type 2 diabetes, glucose, HbA1c, insulin, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, apolipoprotein B, and blood pressure)

This allows us to create a safe, personalized peptide treatment stack

10.1179/1476830515Y.0000000006

[PubMed] [Google Scholar] 10.Maquart FX, Bellon G, Chaqour B, et al

Look ARG, Gregg EW, Jakicic JM, et al

Xiongwen Lv, orcid.org/0000-0003-2354-0168 This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers